Form D · Biotechnology

ONCOSYNERGY, INC.

Stamford, CT · CIK 0001556747

Offering snapshot reported May 26, 2026 · SEC filing

Reported sold
$6.61M
Offering amount: $8.21M
Investors reported
5
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
May 11, 2026
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
May 26, 2026Initial$6,608,832No comparison5SEC filing
May 16, 2022Amendment$3,452,500$3,202,500vs Nov 24, 20204SEC filing
Aug 30, 2021Amendment$2,452,500No comparisonNot reportedSEC filing
Nov 24, 2020Initial$250,000No comparison1SEC filing
Sep 8, 2020Amendment$3,250,000$3,050,000vs May 24, 20196SEC filing
May 24, 2019Initial$200,000No comparison2SEC filing
May 14, 2018Initial$20,006,575No comparison23SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-585097
Amounts include conversion of outstanding convertible securities.

Source: Form D, filed May 26, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
W. Shawn Carbonell Director, Executive
Anne Marie Carbonell Director, Executive
Robert Dunkle Director
Colin Foster Director
Amanda Hayward Director
Hen Suh Park Director
Allen Salmasi Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
2 Ravenglass Dr.
Stamford, CT, 06903